Agilent(CH:AG8)
CHF 144.27-0.40 (-0.27%)
CH:AG8
Agilent stock forecast
CHF 144.27
At close:-0.40 (-0.27%)
Agilent (AG8) Stock Forecast & Price Target
0 Followers
AG8 Analyst Ratings
Strong Buy
12Buy3Hold0Sell
Based on 15 analysts giving stock ratings to Agilent in the past 3 months
AG8 Stock 12 Month Forecast
Average Price Target
CHF153.99▲(6.74% Upside)Based on 15 Wall Street analysts offering 12 month price targets for Agilent in the last 3 months. The average price target is CHF 153.99 with a high forecast of CHF 164.39 and a low forecast of CHF 125.81. The average price target represents a 6.74% change from the last price of CHF 144.27.
Past 12 Months12 Month ForecastJan2026Oct2026
HighCHF164.39
AverageCHF153.99
LowCHF125.81
Highest Price TargetHighestCHF164.39Average Price TargetCHF153.99Lowest Price TargetLowestCHF125.81
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Justin Bowers | Deutsche Bank | CHF159.36 | buy | 10.46%Upside | Initiated | 10/26/26 | ||
| Eve Burstein | Bernstein | CHF150.97 | buy | 4.65%Upside | Assigned | 10/19/26 | ||
| Doug Schenkel | UBS | CHF150.97 | hold | 4.65%Upside | Reiterated | 10/14/26 | ||
| Kallum Titchmarsh | Morgan Stanley | CHF146.78→CHF159.36 | buy | 10.46%Upside | Assigned | 10/13/26 | ||
| Daniel Brennan | TD Cowen | CHF150.97→CHF164.39 | buy | 13.95%Upside | Assigned | 10/13/26 | ||
| Avantika Dhabaria | Bank of America Securities | CHF150.97→CHF159.36 | buy | 10.46%Upside | Reiterated | 10/13/26 | ||
| Luke Sergott | Barclays | CHF146.78→CHF163.55 | buy | 13.37%Upside | Reiterated | 10/07/26 | ||
| Evie Koslosky | Goldman Sachs | CHF146.78→CHF155.16 | buy | 7.55%Upside | Reiterated | 09/20/26 | ||
| John Dunigan | Jefferies | CHF151.81 | hold | 5.23%Upside | Reiterated | 09/17/26 | ||
| Daniel Arias | Stifel Nicolaus | CHF150.97 | buy | 4.65%Upside | Reiterated | 08/30/26 | ||
| Patrick B Donnelly | Citi | CHF155.16→CHF159.36 | buy | 10.46%Upside | Reiterated | 08/27/26 | ||
| Casey Woodring | J.P. Morgan | CHF150.97→CHF159.36 | buy | 10.46%Upside | Reiterated | 08/27/26 | ||
| Vijay Kumar | Evercore ISI | CHF124.13→CHF144.26 | buy | >-0.01%Downside | Reiterated | 08/27/26 | ||
| David Westenberg | Piper Sandler | CHF125.81 | hold | -12.79%Downside | Reiterated | 08/27/26 | ||
| Dan Leonard | RBC Capital | CHF130.00→CHF155.16 | buy | 7.55%Upside | Reiterated | 08/26/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Justin BowersDeutsche Bank | BuyInitiatedCHF159.36 | 10/26/26 | 10.46%Upside | ||
| Eve BursteinBernstein | BuyAssignedCHF150.97 | 10/19/26 | 4.65%Upside | ||
| Doug SchenkelUBS | HoldReiteratedCHF150.97 | 10/14/26 | 4.65%Upside | ||
| Kallum TitchmarshMorgan Stanley | BuyAssignedCHF146.78→CHF159.36 | 10/13/26 | 10.46%Upside | ||
| Daniel BrennanTD Cowen | BuyAssignedCHF150.97→CHF164.39 | 10/13/26 | 13.95%Upside | ||
| Avantika DhabariaBank of America Securities | BuyReiteratedCHF150.97→CHF159.36 | 10/13/26 | 10.46%Upside | ||
| Luke SergottBarclays | BuyReiteratedCHF146.78→CHF163.55 | 10/07/26 | 13.37%Upside | ||
| Evie KosloskyGoldman Sachs | BuyReiteratedCHF146.78→CHF155.16 | 09/20/26 | 7.55%Upside | ||
| John DuniganJefferies | HoldReiteratedCHF151.81 | 09/17/26 | 5.23%Upside | ||
| Daniel AriasStifel Nicolaus | BuyReiteratedCHF150.97 | 08/30/26 | 4.65%Upside | ||
| Patrick B DonnellyCiti | BuyReiteratedCHF155.16→CHF159.36 | 08/27/26 | 10.46%Upside | ||
| Casey WoodringJ.P. Morgan | BuyReiteratedCHF150.97→CHF159.36 | 08/27/26 | 10.46%Upside | ||
| Vijay KumarEvercore ISI | BuyReiteratedCHF124.13→CHF144.26 | 08/27/26 | >-0.01%Downside | ||
| David WestenbergPiper Sandler | HoldReiteratedCHF125.81 | 08/27/26 | -12.79%Downside | ||
| Dan LeonardRBC Capital | BuyReiteratedCHF130.00→CHF155.16 | 08/26/26 | 7.55%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Agilent
3 Months
Success Rate19/28 ratings generated profit
68%
Average Return
+5.47%
Copying Dan Leonard's trades and holding each position for 3 Months would result in 67.86% of your transactions generating a profit, with an average return of +5.47% per trade.
1 Year
Success Rate23/28 ratings generated profit
82%
Average Return
+25.05%
Copying Dan Leonard's trades and holding each position for 1 Year would result in 82.14% of your transactions generating a profit, with an average return of +25.05% per trade.
2 Years
Success Rate18/21 ratings generated profit
86%
Average Return
+22.88%
Copying Patrick B Donnelly's trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +22.88% per trade.
AG8 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 0 | 0 |
| Buy | 15 | 20 | 21 | 27 | 13 |
| Hold | 3 | 4 | 7 | 7 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 20 | 25 | 28 | 34 | 19 |
In the current month, AG8 has received 13 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. AG8 average Analyst price target in the past 3 months is 153.99.
AG8 Financial Forecast
HighCHF1.46
ConsensusCHF1.45
LowCHF1.43
AG8 Earnings Forecast
Next quarter’s earnings estimate for AG8 is CHF 1.45 with a range of CHF 1.43 to CHF 1.46. The previous quarter’s EPS was CHF 1.36. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighCHF1.67B
ConsensusCHF1.67B
LowCHF1.66B
AG8 Sales Forecast
Next quarter’s sales forecast for AG8 is CHF 1.67B with a range of CHF 1.66B to CHF 1.67B. The previous quarter’s sales results were CHF 1.58B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
AG8 Stock Forecast FAQ
What is CH:AG8’s average 12-month price target, according to analysts?
Based on analyst ratings, Agilent’s 12-month average price target is CHF153.99.
What is CH:AG8’s upside potential, based on the analysts’ average price target?
Agilent has 6.74% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Agilent a Buy, Sell or Hold?
Agilent has a consensus rating of Strong Buy, which is based on 12 buy ratings, 3 hold ratings and 0 sell ratings.
What is Agilent’s share price target?
The average share price target for Agilent is CHF153.99. This is based on 15 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF164.39, and the lowest forecast is CHF125.81. The average share price target represents a 6.74% increase from the current price of CHF144.266.
What do analysts say about Agilent?
Agilent’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Street analysts.
How can I buy shares of Agilent?
To buy shares of CH:AG8, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
